These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19047754)

  • 21. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)].
    Shimada K; Terai T; Igari J; Inoue H; Nakadate T; Oguri T; Suwabe A; Obata R; Ikemoto H; Ohno I; Okada S; Hayashi K; Mori T; Nakano K; Arakawa M; Gejyo F; Igarashi K; Yokouchi H; Okada M; Ito A; Sumitomo M; Aoki N; Matsushima T; Niki Y; Kitamura N; Suga M; Suzuki Y; Karasawa Y; Tosaka M; Nakata K; Nakatani T; Kohno S; Tomono K; Miyazaki Y; Inagawa H; Hirakata Y; Aoki S; Matsuda J; Kudo K; Kobayashi N; Kinoshita T; Konosaki H; Nasu M; Nagai H; Kobayashi H; Kawai S; Takayasu S; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2002 Oct; 55(5):537-67. PubMed ID: 12532637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae.
    Lin YW; Abdul Rahim N; Zhao J; Han ML; Yu HH; Wickremasinghe H; Chen K; Wang J; Paterson DL; Zhu Y; Rao GG; Zhou QT; Forrest A; Velkov T; Li J
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooperative action of SP-A and its trimeric recombinant fragment with polymyxins against Gram-negative respiratory bacteria.
    Coya JM; Fraile-Ágreda V; de Tapia L; García-Fojeda B; Sáenz A; Bengoechea JA; Kronqvist N; Johansson J; Casals C
    Front Immunol; 2022; 13():927017. PubMed ID: 36159837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectroscopic investigations of the binding mechanisms between antimicrobial peptides and membrane models of Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Chai H; Allen WE; Hicks RP
    Bioorg Med Chem; 2014 Aug; 22(15):4210-22. PubMed ID: 24931276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae.
    Diep JK; Sharma R; Ellis-Grosse EJ; Abboud CS; Rao GG
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural Anti-Infective Pulmonary Proteins: In Vivo Cooperative Action of Surfactant Protein SP-A and the Lung Antimicrobial Peptide SP-BN.
    Coya JM; Akinbi HT; Sáenz A; Yang L; Weaver TE; Casals C
    J Immunol; 2015 Aug; 195(4):1628-36. PubMed ID: 26163587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of polymyxin susceptibility profile among KPC-producing Klebsiella pneumoniae using Etest and MicroScan WalkAway automated system.
    Perez LR
    APMIS; 2015 Nov; 123(11):951-4. PubMed ID: 26361367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
    Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
    Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY.
    Landman D; Bratu S; Kochar S; Panwar M; Trehan M; Doymaz M; Quale J
    J Antimicrob Chemother; 2007 Jul; 60(1):78-82. PubMed ID: 17490999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.
    Bratu S; Tolaney P; Karumudi U; Quale J; Mooty M; Nichani S; Landman D
    J Antimicrob Chemother; 2005 Jul; 56(1):128-32. PubMed ID: 15917285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals.
    Sutherland CA; Nicolau DP
    Clin Ther; 2015 Jul; 37(7):1564-71. PubMed ID: 26088525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae.
    Diep JK; Jacobs DM; Sharma R; Covelli J; Bowers DR; Russo TA; Rao GG
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in the bactericidal activity of selected cathelicidin peptides by bovine calf serum or exogenous endotoxin.
    Bartlett KH; McCray PB; Thorne PS
    Int J Antimicrob Agents; 2004 Jun; 23(6):606-12. PubMed ID: 15194132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NMR Study of the Secondary Structure and Biopharmaceutical Formulation of an Active Branched Antimicrobial Peptide.
    Castiglia F; Zevolini F; Riolo G; Brunetti J; De Lazzari A; Moretto A; Manetto G; Fragai M; Algotsson J; Evenäs J; Bracci L; Pini A; Falciani C
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31775296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiological Assessment of Polymyxin B Components Tested Alone and in Combination.
    Kassamali Z; Prince RA; Danziger LH; Rotschafer JC; Rhomberg PR; Jones RN
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7823-5. PubMed ID: 26392511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico design of polycationic antimicrobial peptides active against Pseudomonas aeruginosa and Staphylococcus aureus.
    Hincapié O; Giraldo P; Orduz S
    Antonie Van Leeuwenhoek; 2018 Oct; 111(10):1871-1882. PubMed ID: 29626331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro potency of various polymyxin B components.
    Tam VH; Cao H; Ledesma KR; Hu M
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4490-1. PubMed ID: 21709096
    [No Abstract]   [Full Text] [Related]  

  • 40. First two cases of severe multifocal infections caused by Klebsiella pneumoniae in Switzerland: characterization of an atypical non-K1/K2-serotype strain causing liver abscess and endocarditis.
    Babouee Flury B; Donà V; Buetti N; Furrer H; Endimiani A
    J Glob Antimicrob Resist; 2017 Sep; 10():165-170. PubMed ID: 28729207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.